Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00313937
What this trial is testing

SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1

Who this might be right for
Diabetes Mellitus, Type 1
Sanofi 91
Testing effectiveness (Phase 2)Study completedNCT02412228
What this trial is testing

Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma

Who this might be right for
Multiple Myeloma
John L. Reagan 12
Testing effectiveness (Phase 2)Temporarily pausedNCT06572605
What this trial is testing

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

Who this might be right for
Extramedullary Disease in Multiple MyelomaMultiple Myeloma
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06758375
What this trial is testing

Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Hospital Universitario Dr. Jose E. Gonzalez 10
Not applicableStudy completedNCT03001128
What this trial is testing

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 61
Large-scale testing (Phase 3)Active Not RecruitingNCT04459416
What this trial is testing

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Who this might be right for
Multiple MyelomaHodgkin DiseaseNon-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 299
Early research (Phase 1)Study completedNCT04811898
What this trial is testing

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

Who this might be right for
Multiple Myeloma, RefractoryHepatocarcinomaAdvanced Solid Tumor
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 17
Testing effectiveness (Phase 2)Study completedNCT04512287
What this trial is testing

PRP for Treatment of Peyronie's Disease

Who this might be right for
Peyronie DiseaseSexual Dysfunction, PhysiologicalSexual Dysfunction Male+1 more
University of Miami 65
Post-approval studies (Phase 4)Study completedNCT01432405
What this trial is testing

Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Baylor College of Medicine 24
Not applicableStudy completedNCT00818298
What this trial is testing

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 12
Early research (Phase 1)Study completedNCT01998971
What this trial is testing

JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 240
Not applicableLooking for participantsNCT07184307
What this trial is testing

Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial

Who this might be right for
Overactive Bladder SyndromeUrinary Urge IncontinenceDetrusor Overactivity
Benha University 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07474961
What this trial is testing

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

Who this might be right for
Waldenstrom MacroglobulinaemiaMultiple Myeloma
Anne Louise Tølbøll Sørensen 400
Not applicableStudy completedNCT06852131
What this trial is testing

Carpal Tunnel Syndrome Treatment: Surgery Vs. Injections

Who this might be right for
Carpal Tunnel Syndrome (CTS)
Ankara University 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Testing effectiveness (Phase 2)Study completedNCT00689000
What this trial is testing

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma
Chroma Therapeutics 57
Very early researchNot Yet RecruitingNCT07586709
What this trial is testing

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

Who this might be right for
Plasma Cell Neoplasms
Liping Dou 18
Testing effectiveness (Phase 2)WithdrawnNCT02118311
What this trial is testing

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota
Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Not applicableNo Longer AvailableNCT02666209
What this trial is testing

Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma
Dana-Farber Cancer Institute
Next Page